Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly vs Three-Weekly Cisplatin in Locally Advanced Head and Neck Cancer
NCT03998696Phase 2Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in head and neck squamous cell carcinoma (HNSCC), sponsored by Bangabandhu Sheikh Mujib Medical University. Started Jan 2024; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT03998696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03998696.